Department of Biostatistics, University of Florida, Gainesville, FL, USA.
J Biopharm Stat. 2023 Sep 3;33(5):575-585. doi: 10.1080/10543406.2023.2170399. Epub 2023 Feb 3.
Response adaptive randomization has the potential to treat more participants in better treatments in a trial to benefit participants. We propose optimal response adaptive randomization designs for a two-stage study with binary response, having the smallest expected sample size or the fewest expected number of failures. Equal randomization is used in the first stage, and data from the first stage is used to determine the adaptive sample size ratio in the second stage. In the proposed optimal designs, the type I error rate and the statistical power are calculated from the asymptotic normal distributions. The new designs that minimize the expected number of failures have the advantage over the existing optimal randomized designs to substantially reduce the number of failures.
响应适应性随机化有可能在试验中为更多参与者提供更好的治疗,从而使参与者受益。我们提出了一种具有二项反应的两阶段研究的最优响应适应性随机化设计,具有最小的预期样本量或最少的预期失败数。第一阶段采用均等随机化,第一阶段的数据用于确定第二阶段的自适应样本大小比。在提出的最优设计中,I 型错误率和统计功效是根据渐近正态分布计算的。与现有的最优随机设计相比,新的最小化失败数的设计具有显著减少失败数的优势。